, The Lancet, Volume 399, 5 March 2022
The Lancet Regional Health - Europe, Volume 13, February 2022
This Article supports SDGs 3 and 10 by assessing SARS-CoV-2 incidence in six ethnic groups in Amsterdam, and showing that incidence was highest in the largest minority ethnic groups. The findings suggest that prevention measures and vaccination should be especially encouraged in these groups.
This study supports SDGs 3 and 6 by showing that a handwashing intervention involving disgust-inducing messages, combined with the provision of handwashing stations in Abidjan, Côte d'Ivoire, successfully increased rates of handwashing with soap after toilet use. These findings demonstrate the effectiveness of combining health-based messaging with non-health-based messaging when implementing water, sanitation, and hygiene interventions.
, The Lancet Planetary Health, Volume 5, March 2021
Climate change can have detrimental effects on child health and wellbeing. Despite the imperative for a fuller understanding of how climate change affects child health and wellbeing, a systematic approach and focus solely on children (aged
, The Lancet, Volume 397, 6 February 2021
Women and children bear substantial morbidity and mortality as a result of armed conflicts. This Series paper focuses on the direct (due to violence) and indirect health effects of armed conflict on women and children (including adolescents) worldwide. We estimate that nearly 36 million children and 16 million women were displaced in 2017, on the basis of international databases of refugees and internally displaced populations.
, Blood, Volume 137, 28 January 2021
Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes is poorly understood. We aimed to identify the association between neighborhood poverty and HCT outcomes for pediatric allogeneic HCT recipients in the Center for International Blood and Marrow Transplant Research database.
, EClinicalMedicine, Volume 29-30, December 2020
Background: Patients from ethnic minority groups are disproportionately affected by Coronavirus disease (COVID-19). We performed a systematic review and meta-analysis to explore the relationship between ethnicity and clinical outcomes in COVID-19. Methods: Databases (MEDLINE, EMBASE, PROSPERO, Cochrane library and MedRxiv) were searched up to 31st August 2020, for studies reporting COVID-19 data disaggregated by ethnicity. Outcomes were: risk of infection; intensive therapy unit (ITU) admission and death. PROSPERO ID: 180654.
, The Lancet Global Health, Volume 8, July 2020
Background: Hepatitis B causes more than 800 000 deaths globally each year. Perinatal infections are a major driver of this burden but can be prevented by vaccination within 24 h of birth. Currently, only 44% of newborn babies in low-income and middle-income countries (LMICs) receive a timely birth dose. We investigated the effects and cost-effectiveness of implementing ambient storage of hepatitis B vaccines under a controlled temperature chain (CTC) protocol and the use of compact prefilled auto-disable (CPAD) devices for community births.
, Clinical Microbiology and Infection, Volume 24, April 2018
Objectives: This paper review trends in emerging infections and the need for increased clinical and laboratory surveillance. Methods: Factors that contributed to the emergence of recent outbreaks have been reviewed. Known, major outbreaks over the past two decades were reviewed. Results: We identified at least four major drivers of emergent infections: (i) increasing density of the human population; (ii) stress from farmland expansion on the environment; (iii) globalization of the food market and manufacturing; (iv) environmental contamination.
, The Lancet Gastroenterology and Hepatology, Volume 2, December 2017
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in mortality due to hepatitis B and C by 2030. Hepatitis B virus (HBV) is endemic in sub-Saharan Africa, and despite the introduction of universal hepatitis B vaccination and effective antiviral therapy, the estimated overall seroprevalence of hepatitis B surface antigen remains high at 6·1% (95% uncertainty interval 4·6–8·5).